The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of low and high doses of lamivudine ( 3TC ) in
combination with zidovudine ( AZT ) and zalcitabine ( dideoxycytidine; ddC ) in combination
with AZT.
PER 02/27/95 AMENDMENT: To evaluate the efficacy and safety of both blinded and open-label
combination therapy.